Herbicide glyphosate facing ban in Europe? Here’s a backgrounder

Screen Shot at PM

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

It’s hard to find an herbicide like glyphosate. It’s cheap, highly effective, and is generally regarded as one of the safest and most environmentally benign herbicides ever discovered. But a report last year that glyphosate could cause cancer has thrown its future into jeopardy. Now the European Union faces a 30 June deadline to reapprove its use, or glyphosate will not be allowed for sale. Here’s a quick explanation of the issues.

Who uses glyphosate?

Just about everyone who hates weeds.

Why is it controversial?

Environmental advocates have long worried about health effects of pesticides and herbicides, including glyphosate.

What makes glyphosate a big issue in Europe right now?

A bombshell report.

Wait, why didn’t the health reviews of glyphosate come to the same conclusions?

One reason is that they ask different questions. IARC evaluates the hazard of a chemical—in this case, whether it could cause cancer. It does not ask how likely that is to happen, or in how many people.

Read full, original post: Why Europe may ban the most popular weed killer in the world

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-05-01-at-1.29.41-PM
Viewpoint: What happens when whole grains meet modern food manufacturing? Labels don’t tell the whole story.
ChatGPT-Image-Apr-13-2026-02_20_22-PM
Viewpoint: Misinformation infodemic? Why assessing evidence is so challenging 
ChatGPT-Image-Mar-27-2026-11_47_30-AM-2
FDA’s expedited drug reviews are hailed in some quarters but other approval practices are problematic
S
As vaccine rejectionism spreads, measles may be taking a more dangerous turn
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
circular-bioeconomy-should-focus-on-sustainable-wellbeing
GLP podcast: What's wrong with 'doomsday' environmentalism? It's false.
Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.